S100A4 and breast carcinoma: Our analysis of S100A4 expression in human breast cancers showed that its levels were higher in tumors carrying PIK3CAH1047R or TP53R270H or both compared to tumors without these mutations (Additional file 1: Figure S8) though they were not statistically different.